{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:26:32Z","timestamp":1787840792709,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K23AR077073"],"award-info":[{"award-number":["K23AR077073"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81060-3","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T10:01:30Z","timestamp":1736848890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping"],"prefix":"10.1038","volume":"15","author":[{"given":"Hannah L.","family":"Cornman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P.","family":"Alphonse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arbor","family":"Dykema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Kollhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Z","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Parthasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha","family":"Kambala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melika","family":"Marani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla A.","family":"Parr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid P.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan M.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Bream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn G.","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"81060_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clindermatol.2018.12.002","volume":"37","author":"AC Inamadar","year":"2019","unstructured":"Inamadar, A. C. & Ragunatha, S. The rash that becomes an erythroderma. Clin. Dermatol. 37, 88\u201398. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.12.002 (2019).","journal-title":"Clin. Dermatol."},{"key":"81060_CR2","doi-asserted-by":"publisher","unstructured":"Akhyani, M., Ghodsi, Z. S., Toosi, S. & Dabbaghian, H. Erythroderma: a clinical study of 97 cases. BMC Dermatol. 5 https:\/\/doi.org\/10.1186\/1471-5945-5-5 (2005).","DOI":"10.1186\/1471-5945-5-5"},{"key":"81060_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.4103\/0378-6323.198434","volume":"83","author":"R Mathew","year":"2017","unstructured":"Mathew, R. & Sreedevan, V. Erythroderma: A clinicopathological study of 370 cases from a tertiary care center in Kerala. Indian J. Dermatol. Venereol. Leprol. 83, 625. https:\/\/doi.org\/10.4103\/0378-6323.198434 (2017).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"81060_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","volume":"139","author":"LC Tsoi","year":"2019","unstructured":"Tsoi, L. C. et al. Atopic dermatitis is an IL-13-Dominant disease with greater molecular heterogeneity compared to psoriasis. J. Invest. Dermatol. 139, 1480\u20131489. https:\/\/doi.org\/10.1016\/j.jid.2018.12.018 (2019).","journal-title":"J. Invest. Dermatol."},{"key":"81060_CR5","doi-asserted-by":"publisher","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","volume":"7","author":"PM Brunner","year":"2017","unstructured":"Brunner, P. M. et al. The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins. Sci. Rep. 7, 8707. https:\/\/doi.org\/10.1038\/s41598-017-09207-z (2017).","journal-title":"Sci. Rep."},{"key":"81060_CR6","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","volume":"25","author":"K Ghoreschi","year":"2007","unstructured":"Ghoreschi, K., Weigert, C. & R\u00f6cken, M. Immunopathogenesis and role of T cells in psoriasis. Clin. Dermatol. 25, 574\u2013580. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.012 (2007).","journal-title":"Clin. Dermatol."},{"key":"81060_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jaad.2020.03.073","volume":"83","author":"OY Carrasquillo","year":"2020","unstructured":"Carrasquillo, O. Y. et al. Treatment of erythrodermic psoriasis with biologics: A systematic review. J. Am. Acad. Dermatol. 83, 151\u2013158. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.073 (2020).","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"81060_CR8","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/jcm12041662","volume":"12","author":"G Avallone","year":"2023","unstructured":"Avallone, G. et al. Interleukin-17 vs. Interleukin-23 inhibitors in pustular and erythrodermic psoriasis: A retrospective, multicentre cohort study. J. Clin. Med. 12 (4), 1662. https:\/\/doi.org\/10.3390\/jcm12041662 (2023). Published 2023 Feb 19.","journal-title":"J. Clin. Med."},{"key":"81060_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ddg.13718","volume":"17","author":"C Kromer","year":"2019","unstructured":"Kromer, C., Sabat, R., Celis, D. & M\u00f6ssner, R. Systemic therapies of pityriasis rubra pilaris: A systematic review. JDDG: J. Der Deutschen Dermatologischen Gesellschaft. 17, 243\u2013259. https:\/\/doi.org\/10.1111\/ddg.13718 (2019).","journal-title":"JDDG: J. Der Deutschen Dermatologischen Gesellschaft"},{"key":"81060_CR10","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","volume":"153","author":"L Feldmeyer","year":"2017","unstructured":"Feldmeyer, L. et al. Interleukin 23-Helper T cell 17 Axis as a treatment target for Pityriasis Rubra Pilaris. JAMA Dermatol. 153, 304\u2013308. https:\/\/doi.org\/10.1001\/jamadermatol.2016.5384 (2017).","journal-title":"JAMA Dermatol."},{"key":"81060_CR11","doi-asserted-by":"publisher","unstructured":"Kamijo, H. & Miyagaki, T. Mycosis Fungoides and S\u00e9zary Syndrome: Updates and review of current therapy. Curr. Treat. Options Oncol. 22, https:\/\/doi.org\/10.1007\/s11864-020-00809-w (2021).","DOI":"10.1007\/s11864-020-00809-w"},{"key":"81060_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ad.2018.05.011","volume":"109","author":"A Cuellar-Barboza","year":"2018","unstructured":"Cuellar-Barboza, A., Ocampo-Candiani, J. & Herz-Ruelas, M. E. Eritrodermia en el adulto: Un enfoque pr\u00e1ctico para el diagn\u00f3stico y tratamiento. Actas Dermosifiliogr. 109, 777\u2013790. https:\/\/doi.org\/10.1016\/j.ad.2018.05.011 (2018).","journal-title":"Actas Dermosifiliogr."},{"key":"81060_CR13","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jid.2021.02.749","volume":"141","author":"M Belzberg","year":"2021","unstructured":"Belzberg, M. et al. Prurigo Nodularis is characterized by systemic and cutaneous T helper 22 Immune polarization. J. Invest. Dermatol. 141, 2208\u20132218e14. https:\/\/doi.org\/10.1016\/j.jid.2021.02.749 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"81060_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4314 (2018).","journal-title":"Nat. Biotechnol."},{"key":"81060_CR15","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1038\/s41596-021-00550-0","volume":"16","author":"K Quintelier","year":"2021","unstructured":"Quintelier, K. et al. Analyzing high-dimensional cytometry data using FlowSOM. Nat. Protoc. 16, 3775\u20133801. https:\/\/doi.org\/10.1038\/s41596-021-00550-0 (2021).","journal-title":"Nat. Protoc."},{"key":"81060_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41586-021-04077-y","volume":"600","author":"F Yang","year":"2021","unstructured":"Yang, F. et al. Structure, function and pharmacology of human itch receptor complexes. Nature 600, 164\u2013169. https:\/\/doi.org\/10.1038\/s41586-021-04077-y (2021).","journal-title":"Nature"},{"key":"81060_CR17","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamadermatol.2020.3071","volume":"156","author":"M Kimel","year":"2020","unstructured":"Kimel, M., Zeidler, C., Kwon, P., Revicki, D. & St\u00e4nder, S. Validation of Psychometric properties of the itch numeric rating scale for Pruritus associated with Prurigo Nodularis: A secondary analysis of a randomized clinical trial. JAMA Dermatol. 156, 1354\u20131358. https:\/\/doi.org\/10.1001\/jamadermatol.2020.3071 (2020).","journal-title":"JAMA Dermatol."},{"key":"81060_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay, A. Y. & Khan, G. K. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin. Exp. Dermatol. 19, 210\u2013216. https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x (1994).","journal-title":"Clin. Exp. Dermatol."},{"key":"81060_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","volume":"26","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report. Nat. Med. 26, 236\u2013243. https:\/\/doi.org\/10.1038\/s41591-019-0733-7 (2020).","journal-title":"Nat. Med."},{"key":"81060_CR20","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.jaci.2020.11.028","volume":"147","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8\u2009+\u2009T cells in autoimmunity and cancer. J. Allergy Clin. Immunol. 147, 2370\u20132380. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.028 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"81060_CR21","doi-asserted-by":"publisher","first-page":"eabh1478","DOI":"10.1126\/scitranslmed.abh1478","volume":"14","author":"AM O\u2019Neill","year":"2022","unstructured":"O\u2019Neill, A. M. et al. Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne. Sci. Transl Med. 14, eabh1478. https:\/\/doi.org\/10.1126\/scitranslmed.abh1478 (2022).","journal-title":"Sci. Transl Med."},{"key":"81060_CR22","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3389\/fimmu.2017.00761","volume":"8","author":"M Lawand","year":"2017","unstructured":"Lawand, M., D\u00e9chanet-Merville, J. & Dieu-Nosjean, M. C. Key features of Gamma-Delta T-Cell subsets in Human diseases and their immunotherapeutic implications. Front. Immunol. 8, 761. https:\/\/doi.org\/10.3389\/fimmu.2017.00761 (2017).","journal-title":"Front. Immunol."},{"key":"81060_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/cmi.2011.50","volume":"9","author":"C Hu","year":"2012","unstructured":"Hu, C. et al. Antigen-presenting effects of effector memory V\u03b39V\u03b42 T cells in rheumatoid arthritis. Cell. Mol. Immunol. 9, 245\u2013254. https:\/\/doi.org\/10.1038\/cmi.2011.50 (2012).","journal-title":"Cell. Mol. Immunol."},{"key":"81060_CR24","doi-asserted-by":"publisher","first-page":"627139","DOI":"10.3389\/fimmu.2021.627139","volume":"12","author":"C Qi","year":"2021","unstructured":"Qi, C., Wang, Y., Li, P. & Zhao, J. Gamma delta T cells and their pathogenic role in Psoriasis. Front. Immunol. 12, 627139. https:\/\/doi.org\/10.3389\/fimmu.2021.627139 (2021).","journal-title":"Front. Immunol."},{"key":"81060_CR25","doi-asserted-by":"publisher","first-page":"e15924","DOI":"10.1111\/dth.15924","volume":"35","author":"F Jia","year":"2022","unstructured":"Jia, F., Zhao, Q., Shi, P., Liu, H. & Zhang, F. Dupilumab: Advances in the off-label usage of IL4\/IL13 antagonist in dermatoses. Dermatol. Ther. 35, e15924. https:\/\/doi.org\/10.1111\/dth.15924 (2022).","journal-title":"Dermatol. Ther."},{"key":"81060_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jdermsci.2014.10.003","volume":"77","author":"R Tamagawa-Mineoka","year":"2015","unstructured":"Tamagawa-Mineoka, R. Important roles of platelets as immune cells in the skin. J. Dermatol. Sci. 77, 93\u2013101. https:\/\/doi.org\/10.1016\/j.jdermsci.2014.10.003 (2015).","journal-title":"J. Dermatol. Sci."},{"key":"81060_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu, K. et al. In silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat. Chem. Biol. 13, 529\u2013536. https:\/\/doi.org\/10.1038\/nchembio.2334 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"81060_CR28","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","volume":"139","author":"Q Liu","year":"2009","unstructured":"Liu, Q. et al. Sensory neuron-specific GPCR mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139, 1353\u20131365. https:\/\/doi.org\/10.1016\/j.cell.2009.11.034 (2009).","journal-title":"Cell"},{"key":"81060_CR29","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1111\/all.14213","volume":"75","author":"B Wedi","year":"2020","unstructured":"Wedi, B., Gehring, M. & Kapp, A. The pseudoallergen receptor MRGPRX2 on peripheral blood basophils and eosinophils: Expression and function. Allergy 75, 2229\u20132242. https:\/\/doi.org\/10.1111\/all.14213 (2020).","journal-title":"Allergy"},{"key":"81060_CR30","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","volume":"9","author":"G Porebski","year":"2018","unstructured":"Porebski, G., Kwiecien, K., Pawica, M. & Kwitniewski, M. Mas-related G protein-coupled Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front. Immunol. 9, 3027. https:\/\/doi.org\/10.3389\/fimmu.2018.03027 (2018).","journal-title":"Front. Immunol."},{"key":"81060_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaci.2020.08.027","volume":"147","author":"H K\u00fchn","year":"2021","unstructured":"K\u00fchn, H. et al. Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. J. Allergy Clin. Immunol. 147, 456\u2013469. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.027 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"81060_CR32","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1177\/10600280221135177","volume":"57","author":"LC Quiroga","year":"2023","unstructured":"Quiroga, L. C. & Sabourin, A. A. Review of dual biologics in specialty pharmacy practice. Ann. Pharmacother. 57 (9), 1094\u20131110. https:\/\/doi.org\/10.1177\/10600280221135177 (2023).","journal-title":"Ann. Pharmacother"},{"issue":"1","key":"81060_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s13555-022-00851-6","volume":"13","author":"P Gisondi","year":"2023","unstructured":"Gisondi, P., Maurelli, M., Costanzo, A., Esposito, M. & Girolomoni, G. The combination of Dupilumab with other monoclonal antibodies. Dermatol. Ther. (Heidelb). 13 (1), 7\u201312. https:\/\/doi.org\/10.1007\/s13555-022-00851-6 (2023).","journal-title":"Dermatol. Ther. (Heidelb)"},{"issue":"4","key":"81060_CR34","doi-asserted-by":"publisher","first-page":"e13498","DOI":"10.1111\/dth.13498","volume":"33","author":"R Balestri","year":"2020","unstructured":"Balestri, R., Magnano, M., Girardelli, C. R., Bortolotti, R. & Rech, G. Long-term safety of combined biological therapy in a patient affected by arthropathic psoriasis and atopic dermatitis. Dermatol. Ther. 33 (4), e13498. https:\/\/doi.org\/10.1111\/dth.13498 (2020).","journal-title":"Dermatol. Ther."},{"issue":"4","key":"81060_CR35","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/ajd.13676","volume":"62","author":"PD Mahar","year":"2021","unstructured":"Mahar, P. D., Zubrinich, C. M., Manuelpillai, N. & Foley, P. Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma. Australas J. Dermatol. 62 (4), 506\u2013508. https:\/\/doi.org\/10.1111\/ajd.13676 (2021).","journal-title":"Australas J. Dermatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81060-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81060-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T10:01:33Z","timestamp":1736848893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81060-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["81060"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81060-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Shawn Kwatra is an advisory board member\/consultant for Abbvie, Amgen, Arcutis Biotherapeutics, Aslan Pharmaceuticals, Bristol Myers Squibb, Cara Therapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte Corporation, Johnson & Johnson, Leo Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron Pharmaceuticals, and Sanofi and has served as an investigator for Galderma, Incyte, Pfizer, and Sanofi. He is also on the Executive Board of the Skin of Color Society. All other authors have no conflicts of interest to report. A provisional patent application (patent no. is 63\/422,061) was filed for the workflow used in the creation of this manuscript on November 3, 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1298"}}